Generation of Induced Pluripotent Stem (iPS) Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular Degeneration

CompletedOBSERVATIONAL
Enrollment

187

Participants

Timeline

Start Date

May 23, 2018

Primary Completion Date

March 21, 2019

Study Completion Date

March 21, 2019

Conditions
AMD
Trial Locations (14)

20892

National Institutes of Health Clinical Center, Bethesda

21237

Elman Retina Group, P.A., Rosedale

28210

Charlotte Eye Ear Nose & Throat Associates, Charlotte

30322

Emory University Eye Center, Atlanta

33136

Bascom Palmer Eye Institute, Miami

40509

Retina Vitreous Associates of Kentucky, Lexington

48375

Vision Research ROPARD Foundation/Associated Retinal Consultants, Novi, Novi

49546

Vision Research ROPARD Foundation/Associated Retinal Consultants, Grand Rapids, Grand Rapids

53705

University of Wisconsin-Madison, Madison

75231

Texas Retina Associates, Dallas

84132

John Moran Eye Center, University of Utah, Salt Lake City

90211

Retina-Vitreous Associates Med Group, Beverly Hills

97210

Casey Eye Institute, Portland

02114-3096

Massachusetts Eye and Ear Infirmary, Boston

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT03372746 - Generation of Induced Pluripotent Stem (iPS) Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular Degeneration | Biotech Hunter | Biotech Hunter